News

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.

Dr. James O'Keefe, preventive cardiologist with Saint Luke's Mid America Heart Institute, joins FOX4 to talk about what it is, the pros and cons of intermittent fasting, and who would benefit from it most.

Dr. Suzanne Arnold weighs in on new findings that may help explain how anger contributes to the risk of having a heart attack.

Consumer Reports On Health talked to Dr. Bethany Austin and Austin Workman about strategies to improve quality of life for those living with heart failure.

Kelly Anspaugh received both a heart and kidney transplant at Saint Luke's.

AARP talked to Dr. James O'Keefe about different types of exercise that can help improve longevity.

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and type 2 diabetes had significant improvement in symptoms and physical limitations when taking semaglutide.

Saint Luke’s Mid America Heart Institute today announced results from the STEP HFpEF DM trial.